Correction: Quality and reliability assessment of systemic lupus erythematosus related health information on short video platforms

• by Lingling Gao, Yujie Yang, Yuchen Wang, Kunling Wang, Wanqing Li, Hongrui Wen, Yunan Zhang, Xiangfeng Li, Wei Bai

• September 3, 2026

Global research landscape and emerging trends of tertiary lymphoid structures in autoimmune diseases: a bibliometric analysis

• by Jiaqi Wang, Yiyuanzi Zhao, Xixuan Chen, Tianshu Dong, Zhiyi Feng, Zhongmian Zhang, Zhihong Li

• July 14, 2026

TNFAIP3/A20 dysfunction drives innate and sterile hyperinflammation

• by Karel F. A. Van Damme, Pieter Hertens, Dorine Sichien, Katrien Van der Borght, Justine Van Moorleghem, Sofie De Prijck, Alex Klarenbeek, Els Louagie, Inés Lammens, Stijn Vanhee, Christian Vanhove, Pieter De Bleser, Steven Van Laecke, Amélie Dendooven, Hamida Hammad, Lars Vereecke, Dirk Elewaut, Geert van Loo, Bart N. Lambrecht

• July 17, 2026

FDA Approves Atacicept for IgA Nephropathy

The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.

• by Kathryn Wighton

• July 7, 2026

• 3 min